Immunosuppressive IL-10+ B cells may accumulate at inflammatory or tumor sites through increased cell survival via the enhanced expression of transcription factor C-MAF upon restraint of SLAMF5 receptor-mediated signaling [38]. This evidence concerns the gene IL10 and neoplasm.